Programs, populations, and payments verified via SAMHSA.
- Level of care
- IOP · MAT · Telehealth
- Service settings
- Outpatient, Intensive outpatient treatment, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment
- Therapy approaches
- Anger management, Brief intervention, Cognitive behavioral therapy, Contingency management/motivational incentives, Motivational interviewing, Matrix Model, Relapse prevention, Substance use disorder counseling
- Age groups
- Children/Adolescents
- Special populations
- Adolescents, Young adults, Adult women, Pregnant/postpartum women, Adult men, Criminal justice (other than DUI/DWI)/Forensic clients, Clients with co-occurring mental and substance use disorders, Clients who have experienced trauma
- Medications used
- Acamprosate (Campral®), Disulfiram, Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable), Naltrexone (extended-release, injectable), Non-nicotine smoking/tobacco cessation
- Recovery supports
- Housing services, Assistance with obtaining social services, Mentoring/peer support
- Facility operation
- Local, county, or community government